Insider · CIK 0001578767

Kavanaugh William Michael

Reports to the SEC for 2 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001578767

Forms 4 and 5

Insider transactions

18 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2020-02-14	CTMXCytomX Therapeutics, Inc. · Stock Option (right to buy)A Award	CSO, Head Res.&Non-Clin. Dev.	AAward	+120K sh	—	—	120,000
2019-01-25	CTMXCytomX Therapeutics, Inc. · Stock Option (right to buy)A Award	CSO, Head Res.&Non-Clin. Dev.	AAward	+90K sh	—	—	90,000
2018-01-24	CTMXCytomX Therapeutics, Inc. · Stock Option (right to buy)A Award	CSO, Head Res.&Non-Clin. Dev.	AAward	+75K sh	—	—	75,000
2017-12-08	CTMXCytomX Therapeutics, Inc.M Exercise/Conversion	CSO, Head Res.&Non-Clin. Dev.	MExercise/Conversion	+5,130 sh	$1.57	+$8,079.237	19,047
2017-12-08	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CSO, Head Res.&Non-Clin. Dev.	MExercise/Conversion	−5,130 sh	—	—	240,912
2017-10-04	CTMXCytomX Therapeutics, Inc.M Exercise/Conversion	CSO, Head Res.&Non-Clin. Dev.	MExercise/Conversion	+48.4K sh	$4.47	+$216K	62,285
2017-10-04	CTMXCytomX Therapeutics, Inc.S Sale	CSO, Head Res.&Non-Clin. Dev.	SSale	−48.4K sh	$24.34	−$1.18M	13,917
2017-10-04	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	CSO, Head Res.&Non-Clin. Dev.	MExercise/Conversion	−48.4K sh	—	—	48,368
2017-04-14	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	CSO, Head Res.&Non-Clin. Dev.	AAward	+48.4K sh	—	—	96,736
2017-01-25	CTMXCytomX Therapeutics, Inc. · Stock Option (right to buy)A Award	CSO, Head Res.&Non-Clin. Dev.	AAward	+120K sh	—	—	120,000
2016-09-26	CTMXCytomX Therapeutics, Inc. · Stock Option (Right to Buy)A Award	CSO, Head Res.&Non-Clin. Dev.	AAward	+48.4K sh	—	—	48,368
2016-01-21	CTMXCytomX Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	CSO, Head Res.&Non-Clin. Dev.	AAward	+80K sh	—	—	80,000
2015-12-31	CTMXCytomX Therapeutics, Inc.M Exercise/Conversion	CSO, Head Res.&Non-Clin. Dev.	MExercise/Conversion	+8,917 sh	$6.61	+$59K	13,917
2015-12-31	CTMXCytomX Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	CSO, Head Res.&Non-Clin. Dev.	MExercise/Conversion	−8,917 sh	—	—	76,688
2015-10-14	CTMXCytomX Therapeutics, Inc.P Purchase	CSO, Head Res.&Non-Clin. Dev.	PPurchase	+5,000 sh	$12.00	+$60K	5,000
2015-08-26	CTMXCytomX Therapeutics, Inc. · Emploiyee Stock Option (right to buy)A Award	CSO, Head Res.&Non-Clin. Dev.	AAward	+85.6K sh	—	—	85,605
2015-05-07	CTMXCytomX Therapeutics, Inc. · Employee Stock Option (right to buy)A Award	CSO, Head Res.&Non-Clin. Dev.	AAward	+246K sh	—	—	246,042
2014-08-22	FIVE PRIME THERAPEUTICS, INC.Employee Stock Option (right to buy)A Award	SVP & Chief Scientific Officer	AAward	+15K sh	—	—	15,000

Recent filings

Accepted (ET)
Feb 194
Kavanaugh William Michael0001567619-20-004348
SEC(opens sec.gov)
Jan 294
Kavanaugh William Michael0001567619-19-001866
SEC(opens sec.gov)
Jan 264
Kavanaugh William Michael0001140361-18-003375
SEC(opens sec.gov)
Dec 124
Kavanaugh William Michael0001140361-17-045842
SEC(opens sec.gov)
Oct 64
Kavanaugh William Michael0001140361-17-037761
SEC(opens sec.gov)
Apr 174
CytomX Therapeutics, Inc.0001140361-17-016029
SEC(opens sec.gov)
Jan 274
CytomX Therapeutics, Inc.0001140361-17-003158
SEC(opens sec.gov)
Sep 284
CytomX Therapeutics, Inc.0001140361-16-080947
SEC(opens sec.gov)
Jan 254
CytomX Therapeutics, Inc.0001140361-16-048511
SEC(opens sec.gov)
Dec 314
CytomX Therapeutics, Inc.0001140361-15-046030
SEC(opens sec.gov)
Oct 164
CytomX Therapeutics, Inc.0001140361-15-037812
SEC(opens sec.gov)
Aug 264
FIVE PRIME THERAPEUTICS INC0001123292-14-000867
SEC(opens sec.gov)

Companies

Address

C/O FIVE PRIME THERAPEUTICS, INC. TWO CORPORATE DRIVE

SOUTH SAN FRANCISCO, CA, 94080